THERAPEUTIC POTENTIAL OF METHYLURACIL IN ORAL MUCOSAL DISEASES: CURRENT EVIDENCE AND CLINICAL PERSPECTIVES
Annotatsiya
Diseases of the oral mucosa frequently present with epithelial injury, ulceration, inflammation, pain, and impaired oral intake. Despite the availability of symptomatic, anti-inflammatory, antimicrobial, and protective treatments, management of mucosal lesions remains clinically challenging, particularly when rapid restoration of epithelial integrity is required. Methyluracil (6-methyluracil; dioxomethyltetrahydropyrimidine) is a pyrimidine derivative that has historically been used as a reparative and epithelializing agent. Its proposed biological effects include stimulation of reparative processes, modulation of inflammation, and effects on nucleic-acid metabolism and oxidative processes
Hali tarjima qilinmagan